<code id='B474666D38'></code><style id='B474666D38'></style>
    • <acronym id='B474666D38'></acronym>
      <center id='B474666D38'><center id='B474666D38'><tfoot id='B474666D38'></tfoot></center><abbr id='B474666D38'><dir id='B474666D38'><tfoot id='B474666D38'></tfoot><noframes id='B474666D38'>

    • <optgroup id='B474666D38'><strike id='B474666D38'><sup id='B474666D38'></sup></strike><code id='B474666D38'></code></optgroup>
        1. <b id='B474666D38'><label id='B474666D38'><select id='B474666D38'><dt id='B474666D38'><span id='B474666D38'></span></dt></select></label></b><u id='B474666D38'></u>
          <i id='B474666D38'><strike id='B474666D38'><tt id='B474666D38'><pre id='B474666D38'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:2758
          Jennifer Doudna Feng Zhang CRISPR
          CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

          The revolution started in silence.

          Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

          advertisement

          No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Indian pharmaceutical industry in denial over drug
          Indian pharmaceutical industry in denial over drug

          AchemistworksatapharmaceuticalmanufacturingplantontheoutskirtsofMumbai.Drugmakersinthecountryhavecom

          read more
          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more

          A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

          GaviCEOSethBerkleyissteppingdownatthestartofnextmonth.FABRICECOFFRINI/AFPviaGettyImagesSethBerkley,t